James M. Thorburn
2018 - Twist Bioscience Corp
In 2018, James M. Thorburn earned a total compensation of $1.5M as Chief Financial Officer at Twist Bioscience Corp.
Compensation breakdown
| Non-Equity Incentive Plan | $70,341 |
|---|---|
| Option Awards | $1,286,756 |
| Salary | $134,015 |
| Total | $1,491,112 |
Thorburn received $1.3M in option awards, accounting for 86% of the total pay in 2018.
Thorburn also received $70.3K in non-equity incentive plan and $134K in salary.
Rankings
In 2018, James M. Thorburn's compensation ranked 7,195th out of 14,244 executives tracked by ExecPay. In other words, Thorburn earned more than 49.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,195 out of 14,244 | 50th |
Division Manufacturing | 2,780 out of 5,765 | 52nd |
Major group Chemicals And Allied Products | 1,047 out of 2,128 | 51st |
Industry group Drugs | 884 out of 1,817 | 51st |
Industry Biological Products, Except Diagnostic Substances | 167 out of 339 | 51st |
Source: SEC filing on June 14, 2019.
Thorburn's colleagues
We found two more compensation records of executives who worked with James M. Thorburn at Twist Bioscience Corp in 2018.
News
Twist Bioscience Corp CEO Emily Leproust's 2022 pay jumps 362% to $5.9M
January 6, 2023
Twist Bioscience Corp CEO Emily Leproust's 2021 pay falls 83% to $1.3M
January 4, 2022
Twist Bioscience Corp CEO Emily Leproust's 2020 pay slips 8% to $7.4M
January 7, 2021
Twist Bioscience Corp CFO James Thorburn receives $1.5M in 2018
June 14, 2019